Avricore Health (AVCRF) Beginning Cash Balance (2021 - 2024)

Avricore Health (AVCRF) reported Beginning Cash Balance of -$21991.6 for Q3 2024, little changed quarter-over-quarter from -$21934.2 in Q2 2024.

Avricore Health (AVCRF) Beginning Cash Balance (2021 - 2024) Analysis & Trends

Avricore Health (AVCRF) has 2 years of Beginning Cash Balance data on file, last reported at -$21991.6 in Q3 2024.

Beginning Cash Balance for Q3 2024 came in at -$21991.6, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was -$66189.2 (changed N/A YoY), and the FY2021 annual result was -$797955.4, changed N/A from the prior year.
Beginning Cash Balance steadied at -$21991.6 in Q3 2024 per AVCRF's latest filing, from -$21934.2 in the prior quarter.
Over five years, Beginning Cash Balance peaked at -$21934.2 in Q2 2024 and troughed at -$790099.1 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn
10	Avricore Health	-	-	-

Download Data